Chemoinformaics analysis of Ellagic acid 4-O-xylopyranoside
| Molecular Weight | 434.309 | nRot | 2 |
| Heavy Atom Molecular Weight | 420.197 | nRig | 27 |
| Exact Molecular Weight | 434.049 | nRing | 5 |
| Solubility: LogS | -5.369 | nHRing | 3 |
| Solubility: LogP | 0.283 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 19 |
| nHA | 12 | APOL | 50.6891 |
| nHD | 6 | BPOL | 22.7249 |
| QED | 0.22 |
| Synth | 4.749 |
| Natural Product Likeliness | 1.296 |
| NR-PPAR-gamma | 0.32 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.993 |
| HIA | 0.598 |
| CACO-2 | -6.146 |
| MDCK | 0.0000248 |
| BBB | 0.024 |
| PPB | 0.723476 |
| VDSS | 1.055 |
| FU | 0.268386 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.054 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.003 |
| CL | 1.189 |
| T12 | 0.755 |
| hERG | 0 |
| Ames | 0.633 |
| ROA | 0.046 |
| SkinSen | 0.601 |
| Carcinogencity | 0.231 |
| EI | 0.069 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.67 |
| Antiviral | Yes |
| Prediction | 0.711971 |